Document is current
Any future updates will be listed below
-
Authors
Bai, Lanning
Qian, Xueqian
Zhang, Hui
Yuan, Yi
Cui, Xiaodong
Cheng, Min
Han, Yangyang https://orcid.org/0000-0001-8458-7408
- License Information
-
More Information
Article History
Received: 8 April 2024
Accepted: 11 January 2025
First Online: 6 February 2025
Declarations
:
: The study entitled “Plectin, a novel regulator of ovarian cancer progression” was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals published by the Weifang Medical University. The protocol was approved by the Committee on the Ethics of Animal Experiments of Weifang Medical University (Permit Number: 2021SDL505). All surgery was performed under isoflurane, and every effort was made to minimize suffering.
: The authors declare that they have no competing interests.
